BioStem Technologies to Present at the 16th Annual LD Micro Invitational

BioStem Technologies Inc. (OTC: BSEM), a regenerative medicine company specializing in perinatal tissue allograft products, announced that its management will present at the 16th Annual LD Micro Invitational in Los Angeles, California. The presentation is scheduled for Monday, May 18, 2026, at 1:30 PM ET. Interested parties can access live and archived webcasts on the investors section of the company's website at ir.biostemtechnologies.com.

The LD Micro Invitational is a key event for small-cap and micro-cap companies, providing a platform to connect with institutional investors, analysts, and the broader financial community. BioStem's participation underscores its commitment to increasing visibility among potential investors and highlighting its progress in the regenerative medicine sector. The company's presentation will likely focus on its proprietary technologies, product portfolio, and growth strategy.

BioStem Technologies leverages its BioRetain, CryoTek, and SteriTek processing technologies to develop allograft solutions derived from perinatal tissue. These technologies are designed to preserve the natural properties of the tissue for clinical use. The company's quality management system is accredited by the American Association of Tissue Banks (AATB) and complies with current Good Tissue Practices (cGTP) and current Good Manufacturing Processes (cGMP). Its product lines include Neox, Clarix, VENDAJE, and American Amnion.

The company's allografts are used by clinicians across various specialties, and BioStem has been expanding its clinical research initiatives and commercial footprint. The presentation at the LD Micro Invitational comes as BioStem continues to advance its innovation in regenerative medicine, aiming to address unmet medical needs in wound care, surgical repair, and other areas.

Investors and stakeholders can follow the company's latest developments through its email distribution list, social media channels on X and LinkedIn, or by visiting its newsroom at https://tinyurl.com/bsemnewsroom. The company's website is www.biostemtechnologies.com.